upadacitinib,linaclotide,risankizumab
Abbvie,ironwood pharmaceutical,Boehringer Ingelheim
['$abbv', 'abbvie']
$abbv - abbvie releases new data demonstrating breadth of its gastroenterology portfolio at 2023 digestive disease week 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.